[Middle molecule level and myocardial contractility in kidney patients]

Area of Science:

• Cardiology
• Nephrology
• Biochemistry

Background:

• Chronic renal insufficiency (CRI) affects multiple organ systems, including the cardiovascular system.
• Substances with mean molecular weight, often elevated in uremia, may impact myocardial function.
• Understanding the relationship between uremic toxins and cardiac contractility is crucial for patient management.

Purpose of the Study:

• To investigate the effect of chronic renal insufficiency on myocardial contractility.
• To assess the correlation between serum mean molecular weight levels and cardiac function in CRI patients.
• To differentiate cardiac performance between compensated and terminal stages of CRI.

Main Methods:

• Polycardiographic method used to assess myocardial contractility.
• Study included 50 patients: 30 with compensated CRI and 20 with terminal CRI.
• Serum levels of substances with mean molecular weight were measured and correlated with polycardiographic parameters.

Main Results:

• No significant changes in polycardiogram parameters were observed in patients with compensated renal function.
• Patients with terminal CRI exhibited a hypodynamic phase syndrome and energodynamic heart insufficiency.
• Terminal CRI was associated with a significant increase in serum mean molecular weight levels in uremic patients.

Conclusions:

• Terminal chronic renal insufficiency significantly impairs myocardial contractility, leading to heart failure.
• Elevated serum mean molecular weight levels in uremic patients are linked to cardiac dysfunction.
• Compensated renal function does not appear to significantly alter myocardial contractility parameters.